乙氨基与重症肺癌患者的生存率改善有关:一种倾向性得分匹配的队列研究
Chen Chen1,2, Weijia Zeng1,2, Yunyi Li1,2
1Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
在ICU中使用乙氨基可能会改善重症肺癌患者的存活率. 这项研究发现,在接受乙氨基的患者中,28天死亡率降低,这表明潜在的生存益处.
科学领域:
- 关键护理医学 关键护理医学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙氨基在ICU中很常见,但它对重症肺癌患者的死亡率的影响尚不清楚.
- 肺癌患者面临高死亡率,乙氨基具有免疫调节作用,需要对其预后价值进行研究.
研究的目的:
- 调查乙氨基使用与原发性肺癌重症患者的死亡率之间的关联.
- 为了澄清这种特定的高风险患者群体中乙氨基的预后相关性.
主要方法:
- 使用MIMIC-IV v2.2数据库进行回顾性队列研究.
- 包括1,127名患有原发性肺癌的危急病患者.
- 倾向性得分匹配和治疗权重的逆概率 (IPTW) 用于控制混因素.
主要成果:
- 乙氨基使用与28天死亡率明显降低相关 (HR=0.75,p=0.015).
- 降低了ICU的风险,住院,30天,90天和365天的死亡率被观察到与乙氨基使用.
- 亚组分析强调了65岁以上的患者和SOFA分数≥3.3的患者的益处.
结论:
- 乙氨基的使用与重症肺癌患者的短期和长期死亡率降低有关.
- 研究结果表明,除了症状缓解之外,还存在潜在的生存益处.
- 需要进行前性研究来证实乙氨基在这个人群中的治疗作用.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
相关概念视频
Cancer Survival Analysis
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Sign Test for Matched Pairs
To conduct the sign test, we first calculate the differences in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Introduction to z Scores
z scores...
